AstraZeneca said its COVID-19 vaccine contributed $275 million to first-quarter sales but shaved three cents per share from its earnings, as it posted better-than-expected results and forecast growth in the second half.
#News #Reuters #AstraZeneca
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en